BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company continues to advance its therapies, with the company's BioRetain product receiving approval for a clinical study for the treatment of venous leg ulcers.
